Diamyd Medical Aktiebolag Stock: price and insider trades · Sweden
1 insider bought €918 of shares over the last 90 days, the latest by Mathias Skalmstad, filed 02 Nov 2026.
Diamyd Medical Aktiebolag: what insiders have been doing
This page follows insider dealings at Diamyd Medical Aktiebolag as filed with Finansinspektionen, a company from the Health Care sector. Between 3 November 2025 and 3 November 2026, 2 insiders published 3 filings.
The flow runs one way only: 2 insiders bought (3 purchases totalling €19k) and nobody sold on the market. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. On the buying side, the filings list 1 finance chief and 1 chief executive among the declarants. One trade stands out by size: a purchase of €9,561 from Anders Essen-Möller, disclosed on 30 April 2026.
Across the 1,032 companies tracked on its exchange, the median is 9 filings; at 3 filings, this issuer sits below that mark. The full history, which starts in 2017, counts 38 purchases against 17 sales.
The last insider purchase was made public on 2 November 2026, 6 days ago. Publication is fast: at least half of the trades appear on Finansinspektionen on the same day. Under the Market Abuse Regulation, managers have three business days to notify their trades.
Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and UCB. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Who traded when
BuySaleFinancial data
as of FY 2025FY ended August 2025 · cache
- 10,000 shares@ SEK 1.010.0064% mcap100.0% of flowAktieISIN SE0005162880FI:csv-31d0a152f8912810bc53Canonical exit: 31 Jan 2027 (T+90)
- 100,000 shares@ SEK 0.9770.056% mcap7.1% of flowAktieISIN SE0005162880FI:csv-30c5921d0c19940434f8Canonical exit: 25 Oct 2026 (T+90)
- 100,000 shares@ SEK 1.040.1% of flowAktieISIN SE0005162880FI:csv-8812c470b02b41253b11Canonical exit: 28 Jul 2026 (T+90)
- 100,000 shares0AktieISIN SE0005162880FI:csv-74dac0f282ca7c2dcef3
- 40,749 shares@ SEK 8.00BTU (betald tecknad unit)ISIN SE0024467914FI:csv-32f280c92f00b5164a3e
- 3,437 shares@ SEK 8.00BTU (betald tecknad unit)ISIN SE0024467914FI:csv-521e4df3bdb5459719d6
- 92,594 shares@ SEK 8.00BTU (betald tecknad unit)ISIN SE0024467914FI:csv-8519d5916fa216bddb85
- 40,000 shares@ SEK 11.500.4% of flowAktieISIN SE0022760336FI:csv-fc913942663f469c1483Canonical exit: 12 Feb 2025 (T+90)
- 40,000 shares@ SEK 11.500.4% of flowAktieISIN SE0022760336FI:csv-0513a83c8869a0550a55Canonical exit: 30 Dec 2024 (T+90)
- 319,090 shares@ SEK 11.003.0% of flowBTA (betald tecknad aktie)ISIN SE0003045822FI:csv-8b274c4fff404b62712d
- 12,000 shares0TeckningsoptionISIN SE0020356996FI:csv-5e6950ac9b957b929451
- 6,000 shares@ SEK 11.0013.2% of flowInterimsaktieISIN SE0022760336FI:csv-035b29394c0a7e0837f8
- 319,090 shares@ SEK 125.1194BTA (betald tecknad aktie)ISIN SE0003045822FI:csv-b1bb52af2b06eaaeac83
- 92,703 shares@ SEK 11.000.9% of flowBTA (betald tecknad aktie)ISIN SE0022760336FI:csv-e203e97fbab24e09f23c
- 5,000 shares@ SEK 11.006.6% of flowInterimsaktieISIN SE0022760336FI:csv-ade450786e88f9778a57
- 10,000 shares0TeckningsoptionISIN SE0020356996FI:csv-3ce5c7ef536944d5cd93
- 45,455 shares@ SEK 11.0014.6% of flowInterimsaktieISIN SE0022760336FI:csv-3fd4a7a4bd5a03476603
- 90,910 shares0TeckningsoptionISIN SE0020356996FI:csv-f602f9db1dbb11d3e933
- 53,000 shares@ SEK 16.440.7% of flowAktieISIN SE0005162880FI:csv-a1f8a8f71e1e8368ee7b
- 871,320 shares@ SEK 16.4412.3% of flowAktieISIN SE0005162880FI:csv-436ef84a5685edfebc05
- 28,000 shares@ SEK 16.59513.6% of flowAktieISIN SE0005162880FI:csv-3b4ed2459d43c7f40eed
- 7,570 shares@ SEK 3.0110.7% of flowTeckningsoptionISIN SE0020356996FI:csv-600133a081962e44819fCanonical exit: 28 Nov 2024 (T+90)
- 4,158 shares@ SEK 4.072515.7% of flowTeckningsoptionISIN SE0020357002FI:csv-e376b6d28992763d80e0
- 2,970 shares@ SEK 3.509.6% of flowTeckningsoptionISIN SE0020356996FI:csv-e3b8476b410312b5fa6b
- 9.558 shares@ US$1.3413100.0% of flowAktieISIN SE0005162880FI:csv-82734bf7b9942f700ae8Canonical exit: 6 Oct 2024 (T+90)
25 of 121 declarations
About Diamyd Medical Aktiebolag
Diamyd Medical Aktiebolag is a Swedish biopharmaceutical company focused on developing treatments for type 1 diabetes. It is listed on the Stockholm Stock Exchange.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
